semaglutide for ra GLP-1 agents 'can help lower systemic inflammation,' show promise in rheumatology ACR 2025: GLP-1 Drugs Reduce

L.WenY.YangQ.et al (2024)

2020;105(8):e2695-e2709.

This is usually because it's feeding on certain oils or fatty acids

Single-dose combination of anti-GDF8 and anti-ActA results in greater increases in muscle and lean mass measures, and greater decreases in fat measures, than either mAb alone To understand the contribution of GDF8 and ActA on body composition in humans (healthy postmenopausal females), we administered single doses of the GDF8 and ActA mAbs alone or in combination, and used various measures to assess changes in muscle and fat at weeks 4 and 8: magnetic resonance imaging (MRI) was used to quantitate percent change in thigh muscle volume (Fig

This doesnt mean its a free-for-all

Available at: (Accessed March 15, 2021)